Exelixis: Following a 170% Profit Increase, Groundbreaking Study Results in Cancer Therapy are Published

Reading Time: 3 minutes
With nearly 10 million deaths per year, cancer is one of the leading causes of death overall. Therefore, new treatment options are currently being prioritized in medicine. Cancer immunotherapy holds a special place in this regard. This method supports the body's own immune system to specifically recognize and fight cancer cells. As a result, immunotherapy is typically less burdensome than traditional cancer treatments like chemotherapy, as the new method specifically activates the immune system rather than attacking both healthy and diseased cells...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.